JM Financial Limited (BOM: 523405)
India
· Delayed Price · Currency is INR
117.25
-2.20 (-1.84%)
At close: Jan 17, 2025
JM Financial Revenue
JM Financial had revenue of 6.39B INR in the quarter ending September 30, 2024, a decrease of -8.58%. This brings the company's revenue in the last twelve months to 27.04B, up 20.32% year-over-year. In the fiscal year ending March 31, 2024, JM Financial had annual revenue of 26.82B with 29.56% growth.
Revenue (ttm)
27.04B
Revenue Growth
+20.32%
P/S Ratio
4.10
Revenue / Employee
93.23M
Employees
290
Market Cap
110.96B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 26.82B | 6.12B | 29.56% |
Mar 31, 2023 | 20.70B | -2.73B | -11.65% |
Mar 31, 2022 | 23.43B | 4.86B | 26.20% |
Mar 31, 2021 | 18.56B | 2.03B | 12.25% |
Mar 31, 2020 | 16.54B | -3.83B | -18.81% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
Tata Consultancy Services | 2,520.82B |
HDFC Bank | 2,761.06B |
Bharti Airtel | 1,554.78B |
ICICI Bank | 1,638.51B |
Infosys | 1,635.60B |
State Bank of India | 3,360.28B |
Hindustan Unilever | 624.10B |
JM Financial News
- 4 days ago - Buy or sell: Stocks on brokerages’ radar for today - The Times of India
- 6 days ago - JM Financial on India’s cement sector: Top picks UltraTech, Ambuja, and JK Cement – check target - Business Upturn
- 14 days ago - Indiamart shares up nearly 4% as JM Financial upgrades to ‘Buy’ - Business Upturn
- 18 days ago - JM Financial receives administrative warning from SEBI over Western Carrier (India) IPO - Business Upturn
- 4 weeks ago - Stocks on brokerages’ radar for December 18 - The Times of India
- 5 weeks ago - Piramal Pharma shares surge 3% after JM Financial initiates ‘Buy’ rating - Business Upturn
- 5 weeks ago - JM Financial initiates ‘Buy’ on Piramal Pharma, sets target price at ₹340 - Business Upturn
- 5 weeks ago - Buy or sell: Stocks on brokerages’ radar for today - The Times of India